Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
Recruiting · NCT06408584 · Registry updated 2024-05-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Not stated | 2024-05-21 | NCT06408584 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anhui Provincial Hospital | 101 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yuan He | Hefei | China | 1 |